首页> 美国卫生研究院文献>Advances in Hematology >Thalassemia and Hemoglobin E in Southern Thai Blood Donors
【2h】

Thalassemia and Hemoglobin E in Southern Thai Blood Donors

机译:泰国南部献血者的地中海贫血和血红蛋白E

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining the frequency of α-thalassemia 1 trait, β-thalassemia trait, and Hb E-related syndromes in Southern Thai blood donors. One hundred and sixteen voluntary blood donors, Southern Thailand origin, were recruited for thalassemia and Hb E screening by red blood cell indices/dichlorophenolindophenol precipitation test. β-Thalassemia and Hb E were then identified by high performance liquid chromatography and 4 common α-thalassemia deletions were characterized by a single tube-multiplex gap-polymerase chain reaction. Overall frequency of hemoglobinopathies was 12.9%, classified as follows: homozygous α-thalassemia 2 (1.7%), heterozygous α-thalassemia 1 (1.7%), heterozygous β-thalassemia without α-thalassemia (0.9%), heterozygous Hb E without α-thalassemia (5.2%), double heterozygotes for Hb E/α-thalassemia 1 (1.7%), homozygous Hb E without α-thalassemia (0.9%), and homozygous Hb E with heterozygous α-thalassemia 2 (0.9%). The usefulness of thalassemia screening is not only for receiving highly effective red blood cells in the recipients but also for encouraging the control and prevention program of thalassemia in blood donors.
机译:地中海贫血和血红蛋白E(Hb E)在泰国很常见。具有地中海贫血特征的个体通常血红蛋白浓度正常或轻度贫血。因此,可接受的血红蛋白水平最低的地中海贫血患者可被视为献血者。这项研究的目的是确定泰国南部献血者中α-地中海贫血1性状,β-地中海贫血性状和Hb E相关综合征的发生率。通过红细胞指数/二氯苯酚吲哚酚沉淀试验,招募了116名泰国南部籍自愿献血者进行地中海贫血和Hb E筛查。然后通过高效液相色谱法鉴定β-地中海贫血和Hb E,并通过单管多重缺口聚合酶链反应表征4个常见的α-地中海贫血缺失。血红蛋白病的总体发生率为12.9%,分类如下:纯合性α地中海贫血2(1.7%),杂合性α地中海贫血1(1.7%),无α地中海贫血的杂合性β地中海贫血(0.9%),无α杂合性Hb E -地中海贫血(5.2%),Hb E /α-地中海贫血1的双重杂合子(1.7%),无α-地中海贫血的纯合Hb E(0.9%)和具有α-地中海贫血2的纯合Hb E(0.9%)。地中海贫血筛查的有用之处不仅在于在接受者中接受高效的红细胞,还在于鼓励献血者地中海贫血的控制和预防计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号